Viatris Inc
NASDAQ:VTRS
Viatris Inc
NASDAQ:VTRS
Price:
10.47 USD
0.48%
Market Closed
Updated:
Jun 9, 2024
Viatris Inc
Accrued Liabilities
|
Viatris Inc
Accrued Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Viatris Inc
NASDAQ:VTRS
|
Accrued Liabilities
$2.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Accrued Liabilities
$28.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Accrued Liabilities
$9.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Accrued Liabilities
$2.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Accrued Liabilities
$13.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Accrued Liabilities
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
See Also
What is Viatris Inc's Accrued Liabilities?
Accrued Liabilities
2.3B
USD
2.3B
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Accrued Liabilities amounts to 2.3B USD.
What is Viatris Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
12%
12%
Over the last year, the Accrued Liabilities growth was 6%. The average annual Accrued Liabilities growth rates for Viatris Inc have been -8% over the past three years , 11% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
